FinanceAsianet Newsable
MNKD Stock Rises Premarket As FDA Verdict Nears
in5points
MannKind Corporation's stock is rising in premarket trading.
The FDA is expected to decide on MannKind's supplemental New Drug Application (sNDA).
The FDA announcement is scheduled for July 26, 2026.
The stock movement is linked to the anticipated FDA verdict.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically